BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) dropped 0.2% during mid-day trading on Monday . The company traded as low as $10.91 and last traded at $11.98. Approximately 41,955 shares were traded during mid-day trading, a decline of 38% from the average daily volume of 67,777 shares. The stock had previously closed at $12.00.
BioStem Technologies Stock Down 3.6%
The firm has a market capitalization of $187.42 million, a price-to-earnings ratio of 16.50 and a beta of -0.10. The stock's fifty day moving average is $11.53 and its two-hundred day moving average is $13.48.
BioStem Technologies (OTCMKTS:BSEM - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $0.17 earnings per share for the quarter, missing analysts' consensus estimates of $1.25 by ($1.08). The company had revenue of $72.53 million for the quarter, compared to analyst estimates of $101.20 million. As a group, analysts anticipate that BioStem Technologies, Inc. will post 1.41 EPS for the current year.
About BioStem Technologies
(
Get Free Report)
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
See Also
Before you consider BioStem Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioStem Technologies wasn't on the list.
While BioStem Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
